# The Effect of Etelcalcetide on CKD-MBD

> **NCT03960437** · PHASE2 · COMPLETED · sponsor: **Thomas Nickolas, MD MS** · enrollment: 22 (actual)

## Conditions studied

- Chronic Kidney Disease Mineral and Bone Disorder
- Renal Osteodystrophy
- Vascular Calcification
- Hyperparathyroidism; Secondary, Renal

## Interventions

- **DRUG:** Etelcalcetide

## Key facts

- **NCT ID:** NCT03960437
- **Lead sponsor:** Thomas Nickolas, MD MS
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-06
- **Primary completion:** 2020-11-19
- **Final completion:** 2020-11-19
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03960437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03960437, "The Effect of Etelcalcetide on CKD-MBD". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03960437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*